Abstract

A comparative analysis of the impact of citicoline, α-lipoic acid, nicergoline, donepezil and colloidal solution of nano-silver (CSNS) on the processes of learning and consolidation of memorable track in the test of the conditional reaction of passive avoidance (CRPA) in conditions of experimental allergic encephalomyelitis (EAE) was conducted. Testing of passive defensive skill was performed on days 12 and 20 after the induction of EAE. To assess the impact of drugs on the inputted information processes the investigated substances were administered intragastrically (CSNS - intraperitoneally) once daily in the definite dose from the second to the day 10 after the induction of EAE (latent phase of the disease), and assessing processes of conditional skill preserving, further administration of drugs by the day 20 of the experiment (average duration of EAE) was used. A positive effect of citicoline, α-lipoic acid, nicergoline and donepezil on the input information processes and the ability to prevent accelerated extinction of acquired contingent skill in the conditions of experimental pathology was established. Drugs statistically significantly increased duration of the latent period of CRPA in comparison with a group of active control by 49%, 43%, 39% and 34%, respectively. Here with preparations were characterized by a high coefficient of antiamnesic activity, by the end of the experiment it was recorded at the level of 95% (citicoline), 81% (α-lipoic acid), 76% (nicergoline) and 53% (donepezil). It is shown that the ability to prevent development of cognitive impairment in conditions of experimental equivalent of multiple sclerosis decreases in the number of citicoline (500 mg/kg) > α-lipoic acid (50 mg/kg) ≈ nicergoline (10 mg/kg) > donepezil (10 mg/kg).

Highlights

  • Possibilities of pharmacologic correction of cognitive disorders in conditions of experimental equivalent of multiple sclerosis

  • Testing of passive defensive skill was performed on days 12

  • Here with preparations were characterized by a high coefficient of antiamnesic activity

Read more

Summary

Introduction

Possibilities of pharmacologic correction of cognitive disorders in conditions of experimental equivalent of multiple sclerosis. Ⱦɥɹ ɷɬɨɝɨ ɩɪɨɜɟɞɟɧ ɫɪɚɜɧɢɬɟɥɶɧɵɣ ɚɧɚɥɢɡ ɜɥɢɹɧɢɹ ɰɢɬɢɤɨɥɢɧɚ, Į-ɥɢɩɨɟɜɨɣ ɤɢɫɥɨɬɵ, ɧɢɰɟɪɝɨɥɢɧɚ, ɞɨɧɟɩɟɡɢɥɚ ɢ ɤɨɥɥɨɢɞɧɨɝɨ ɪɚɫɬɜɨɪɚ ɧɚɧɨɫɟɪɟɛɪɚ (ɄɊɇɋ) ɧɚ ɩɪɨɰɟɫɫɵ ɨɛɭɱɟɧɢɹ ɢ ɤɨɧɫɨɥɢɞɚɰɢɢ ɩɚɦɹɬɧɨɝɨ ɫɥɟɞɚ ɜ ɬɟɫɬɟ ɭɫɥɨɜɧɨɣ ɪɟɚɤɰɢɢ ɩɚɫɫɢɜɧɨɝɨ ɢɡɛɟɝɚɧɢɹ (ɍɊɉɂ) ɜ ɭɫɥɨɜɢɹɯ ɗȺɗ. Ɋɟɡɭɥɶɬɚɬɵ ɩɪɨɜɟɞɟɧɧɵɯ ɢɫɫɥɟɞɨɜɚɧɢɣ ɫɜɢɞɟɬɟɥɶɫɬɜɭɸɬ, ɱɬɨ ɧɚ 10 ɫɭɬɤɢ ɜɜɟɞɟɧɢɹ ɩɪɟɩɚɪɚɬɨɜ ɩɨɫɥɟ ɨɞɧɨɤɪɚɬɧɨɣ ɩɨɞɤɨɠɧɨɣ ɢɧɨɤɭɥɹɰɢɢ ɗȽɋ ɜ ɩɨɥɧɨɦ ɚɞɴɸɜɚɧɬɟ Ɏɪɟɣɧɞɚ ɥɚɬɟɧɬɧɵɣ ɩɟɪɢɨɞ (Ʌɉ1) ɡɚɯɨɞɚ ɠɢɜɨɬɧɵɯ ɜ ɬɟɦɧɵɣ ɨɬɫɟɤ ɤɚɦɟɪɵ (ɞɨ ɧɚɱɚɥɚ ɮɨɪɦɢɪɨɜɚɧɢɹ ɍɊɉɂ) ɫɭɳɟɫɬɜɟɧɧɨ ɧɟ ɨɬɥɢɱɚɥɫɹ ɜɨ ɜɫɟɯ ɝɪɭɩɩɚɯ

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.